Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate-to-Severe Plaque Psoriasis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT04263610
What this trial is testing

Efficacy and Safety of Tildrakizumab in Participants With Moderate-to-Severe Chronic Plaque Psoriasis Who Are Non-Responders to Dimethyl Fumarate Therapy

Who this might be right for
Plaque Psoriasis
Almirall, S.A. 190
Large-scale testing (Phase 3)Study completedNCT03818035
What this trial is testing

Evaluate Further Therapeutic Strategies With Guselkumab in Participants With Moderate-to-Severe Plaque-Type Psoriasis

Who this might be right for
Psoriasis
Janssen-Cilag International NV 880
Post-approval studies (Phase 4)Not Yet RecruitingNCT06779097
What this trial is testing

Phase IV Study: Vunakizumab Efficacy and Safety in Moderate-to-severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 1,564
Not applicableLooking for participantsNCT06258668
What this trial is testing

Real-World Safety and Effectiveness of Sotyktu (Deucravacitinib) in Patients With Moderate-to-Severe Plaque Psoriasis in Korea

Who this might be right for
Moderate-to-severe Plaque Psoriasis
Bristol-Myers Squibb 505
Large-scale testing (Phase 3)Study completedNCT04673786
What this trial is testing

Compare the Efficacy and Safety of CT-P43 to Stelara in Patients With Plaque Psoriasis

Who this might be right for
Psoriasis
Celltrion 509
Large-scale testing (Phase 3)Study completedNCT02660580
What this trial is testing

MSB11022 in Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
PsoriasisPlaque Type PsoriasisModerate to Severe Plaque Psoriasis
Fresenius Kabi SwissBioSim GmbH 443
Post-approval studies (Phase 4)Looking for participantsNCT06857942
What this trial is testing

Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

Who this might be right for
PsoriasisOverweight or Obesity
Eli Lilly and Company 200
Testing effectiveness (Phase 2)Ended earlyNCT03179605
What this trial is testing

Assess the Potential for Adrenal Suppression and Systemic Drug Absorption Following Multiple Dosing With DFD-06

Who this might be right for
Psoriasis
Primus Pharmaceuticals 22
Large-scale testing (Phase 3)Study completedNCT02634801
What this trial is testing

Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque Psoriasis Naive to Systemic Treatment

Who this might be right for
Plaque Psoriasis
Eli Lilly and Company 162
Not applicableLooking for participantsNCT06696417
What this trial is testing

Phase IV Study: Vunakizumab Efficacy and Safety in Moderate-to-severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
First Hospital of China Medical University 1,516
Post-approval studies (Phase 4)Ended earlyNCT00972543
What this trial is testing

Raptiva in Palm and Sole Psoriasis

Who this might be right for
Chronic Plaque Psoriasis
Merck KGaA, Darmstadt, Germany 6
Post-approval studies (Phase 4)Ended earlyNCT00739882
What this trial is testing

TRUST Study: Raptiva ® in Hand & Foot Psoriasis

Who this might be right for
Chronic Plaque Psoriasis
Merck KGaA, Darmstadt, Germany 76
Early research (Phase 1)Ended earlyNCT03310320
What this trial is testing

Study to Determine if AZD0284 is Effective and Safe in Treating Plaque Psoriasis

Who this might be right for
Plaque Psoriasis Vulgaris
AstraZeneca 9
Testing effectiveness (Phase 2)Study completedNCT05531682
What this trial is testing

Evaluate the Efficacy and Safety of HB0017 in Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Huabo Biopharm Co., Ltd. 160
Large-scale testing (Phase 3)Study completedNCT01519089
What this trial is testing

A Long Term Study To Evaluate The Safety, Tolerability And Efficacy Of CP-690,550 In Patients With Moderate To Severe Plaque Psoriasis And/Or Psoriatic Arthritis

Who this might be right for
Psoriasis
Pfizer 95
Large-scale testing (Phase 3)Study completedNCT00674063
What this trial is testing

Assess the Efficacy and Safety of Two Dosing Regimens of Alefacept in Subjects Weighing Between 100kg and 150kg With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Chronic Plaque Psoriasis
Astellas Pharma Inc 78
Large-scale testing (Phase 3)Study completedNCT03370133
What this trial is testing

Evaluate the Efficacy and Safety of Bimekizumab Compared to Placebo and an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Chronic Plaque PsoriasisModerate to Severe Chronic Plaque PsoriasisPsoriatic Arthritis
UCB Biopharma SRL 567
Large-scale testing (Phase 3)Study completedNCT02346240
What this trial is testing

Efficacy and Safety Study of Certolizumab Pegol (CZP) Versus Active Comparator and Placebo in Subjects With Plaque Psoriasis (PSO)

Who this might be right for
PsoriasisPlaque Psoriasis
UCB Biopharma S.P.R.L. 559
Large-scale testing (Phase 3)Study completedNCT00574249
What this trial is testing

Adalimumab in Combination With Topical Treatment (Calcipotriol/Betamethasone) in Subjects With Moderate to Severe Psoriasis and Insufficient Response to Classic Systemic Treatment

Who this might be right for
Chronic Plaque Psoriasis
Abbott 730
Not applicableNot Yet RecruitingNCT06811558
What this trial is testing

Ixekizumab Versus Secukizumab in Over 70-year-old Patients with Psoriasis

Who this might be right for
Over 70-year-old Patients with Psoriasis
Second Affiliated Hospital, Zhejiang University, School of Medicine 100
Next Page